Aquinox制药

AQXP NASDAQ
2.390
+0.070
+3.02%
已收盘, 16:00 06/20 EDT
开盘
2.320
昨收
2.320
最高
2.440
最低
2.320
成交量
5.18万
成交均量(3M)
4.90万
52周最高
15.79
52周最低
1.960
换手率
0.22%
市值
5,554.82万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Aquinox制药 AQXP股票价格,Aquinox制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. The Company's primary focus is anti-inflammatory product candidates targeting the Src Homology 2 (SH2)-containing inositol-5-phosphatase 1 (SHIP1) enzyme, which is a regulator of a cellular signaling pathway in immune cells, known as the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) pathway. Its product candidate, AQX-1125, is a small molecule activator of SHIP1 suitable for oral, once daily dosing. The Company is developing AQX-1125 as a treatment in interstitial cystitis/bladder pain syndrome (IC/BPS), a chronic inflammatory disease of the bladder. AQX-1125 is a SHIP1 activator that has demonstrated preliminary safety, anti-inflammatory potential and drug properties in multiple preclinical studies.
展开 >

最近浏览

名称
价格
涨跌幅